Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders
The dopamine D3 receptor has been the subject of a tremendous amount of research since its discovery in 1990. A previous review of this subject [3] described the advances in molecular biology and neuroanatomical localization of the D3 receptor, with a special emphasis on schizophrenia. In the curren...
Saved in:
Published in | Current pharmaceutical design Vol. 9; no. 8; pp. 643 - 671 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United Arab Emirates
Bentham Science Publishers Ltd
01.01.2003
|
Subjects | |
Online Access | Get full text |
ISSN | 1381-6128 1873-4286 |
DOI | 10.2174/1381612033391199 |
Cover
Abstract | The dopamine D3 receptor has been the subject of a tremendous amount of research since its discovery in 1990. A previous review of this subject [3] described the advances in molecular biology and neuroanatomical localization of the D3 receptor, with a special emphasis on schizophrenia. In the current review, we attempt to describe recent advances in the biochemistry and pharmacology of the D3 receptor from the molecular to the behavioral level. Evidence linking an alteration in D3 receptor function as playing an important role in the etiology of a variety of CNS disorders, including schizophrenia, Parkinsons Disease, and substance abuse is also provided. Also discussed are the recent developments in attempting to map the ligand-binding domains of the D2 and D3 receptors. A. survey of the literature, including a description of the medicinal chemistry approaches toward developing D3-selective ligands, is also presented in this review. |
---|---|
AbstractList | The dopamine D3 receptor has been the subject of a tremendous amount of research since its discovery in 1990. A previous review of this subject [3] described the advances in molecular biology and neuroanatomical localization of the D3 receptor, with a special emphasis on schizophrenia. In the current review, we attempt to describe recent advances in the biochemistry and pharmacology of the D3 receptor from the molecular to the behavioral level. Evidence linking an alteration in D3 receptor function as playing an important role in the etiology of a variety of CNS disorders, including schizophrenia, Parkinsons Disease, and substance abuse is also provided. Also discussed are the recent developments in attempting to map the ligand-binding domains of the D2 and D3 receptors. A. survey of the literature, including a description of the medicinal chemistry approaches toward developing D3-selective ligands, is also presented in this review. The dopamine D3 receptor has been the subject of a tremendous amount of research since its discovery in 1990. A previous review of this subject [3] described the advances in molecular biology and neuroanatomical localization of the D3 receptor, with a special emphasis on schizophrenia. In the current review, we attempt to describe recent advances in the biochemistry and pharmacology of the D3 receptor from the molecular to the behavioral level. Evidence linking an alteration in D3 receptor function as playing an important role in the etiology of a variety of CNS disorders, including schizophrenia, Parkinson's Disease, and substance abuse is also provided. Also discussed are the recent developments in attempting to map the ligand-binding domains of the D2 and D3 receptors. A. survey of the literature, including a description of the medicinal chemistry approaches toward developing D3-selective ligands, is also presented in this review. The dopamine D3 receptor has been the subject of a tremendous amount of research since its discovery in 1990. A previous review of this subject [3] described the advances in molecular biology and neuroanatomical localization of the D3 receptor, with a special emphasis on schizophrenia. In the current review, we attempt to describe recent advances in the biochemistry and pharmacology of the D3 receptor from the molecular to the behavioral level. Evidence linking an alteration in D3 receptor function as playing an important role in the etiology of a variety of CNS disorders, including schizophrenia, Parkinson's Disease, and substance abuse is also provided. Also discussed are the recent developments in attempting to map the ligand-binding domains of the D2 and D3 receptors. A. survey of the literature, including a description of the medicinal chemistry approaches toward developing D3-selective ligands, is also presented in this review.The dopamine D3 receptor has been the subject of a tremendous amount of research since its discovery in 1990. A previous review of this subject [3] described the advances in molecular biology and neuroanatomical localization of the D3 receptor, with a special emphasis on schizophrenia. In the current review, we attempt to describe recent advances in the biochemistry and pharmacology of the D3 receptor from the molecular to the behavioral level. Evidence linking an alteration in D3 receptor function as playing an important role in the etiology of a variety of CNS disorders, including schizophrenia, Parkinson's Disease, and substance abuse is also provided. Also discussed are the recent developments in attempting to map the ligand-binding domains of the D2 and D3 receptors. A. survey of the literature, including a description of the medicinal chemistry approaches toward developing D3-selective ligands, is also presented in this review. |
Author | Robert Mach Robert Luedtke |
Author_xml | – sequence: 1 givenname: Robert surname: Luedtke fullname: Luedtke, Robert – sequence: 2 givenname: Robert surname: Mach fullname: Mach, Robert |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/12570797$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc2PFCEQxTtmjfuhd0-GePDWCg3TDcfNjl_JRDdmPROaru5hpQGB3sle9R-XyexqMgdPVXn1exTwzqsT5x1U1UuC3zakY-8I5aQlDaaUCkKEeFKdEd7RmjW8PSl9Gddlzk-r85RuMSaNIOxZdUqaVYc70Z1Vv6-jnyKkhIxDa7gD64NxE1pTtPZBzcYB-gYaQvYRbcyk3JCQSujaZ3DZKItuthBVgCUbjS6nIiY0FvYLLNFbPxldmOI6CCHd661RORZ4bZKPA8T0vHo6KpvgxUO9qL5_eH9z9anefP34-epyU_eMrXLNcUM4YXjQ_dC2nNNR4HZclYevhkEoonivGMNcE6wELUWJngEw0YxqZFTRi-rN4dwQ_c8FUpazSRqsVQ78kmRHMSEdJwV8fQTe-iW6cjfZkBVpKGZ76NUDtPQzDDJEM6t4Lx__tgD4AOjoU4ow_kOw3Mcnj-MrlvbIok1W2XiXozL2f8ZfB2NfAtiqOWkDTsPfjducg9ztdrKEAD9UAgs6S-1n6QO4JdrSu32iMmyDLClGkCqWSC1Ik5J73MjlnbfLDFLs5QUklymoCWTLKP0DJMDQAQ |
CitedBy_id | crossref_primary_10_1371_journal_pone_0049483 crossref_primary_10_3390_molecules23112737 crossref_primary_10_1016_j_bmcl_2009_01_067 crossref_primary_10_1016_j_bmc_2013_03_059 crossref_primary_10_1051_medsci_2005214434 crossref_primary_10_1016_j_nucmedbio_2013_02_011 crossref_primary_10_1021_jm0704200 crossref_primary_10_1021_jm030836n crossref_primary_10_1111_j_1471_4159_2007_04660_x crossref_primary_10_1016_j_neulet_2018_03_006 crossref_primary_10_1016_j_bmc_2011_04_021 crossref_primary_10_1016_j_bmcl_2004_09_047 crossref_primary_10_1002_syn_20725 crossref_primary_10_1021_jm049031l crossref_primary_10_1021_cn300142q crossref_primary_10_1002_syn_21691 crossref_primary_10_1016_j_bmcl_2003_09_083 crossref_primary_10_1021_ci100290f crossref_primary_10_1016_j_cpet_2010_02_002 crossref_primary_10_1016_j_bmc_2004_06_019 crossref_primary_10_1016_j_bmc_2010_05_052 crossref_primary_10_1021_jm701524h crossref_primary_10_1021_jm050729o crossref_primary_10_1021_acs_jmedchem_7b01248 crossref_primary_10_1021_jm040190e crossref_primary_10_1021_jm049465g crossref_primary_10_1016_j_bmcl_2015_12_068 crossref_primary_10_1097_FBP_0b013e32831c3b2b crossref_primary_10_1016_j_bmcl_2006_10_076 crossref_primary_10_1016_j_tips_2010_12_003 crossref_primary_10_1016_j_bmc_2007_08_034 crossref_primary_10_1016_j_bmc_2004_09_054 crossref_primary_10_1016_j_neuroimage_2013_01_007 crossref_primary_10_1002_syn_20652 crossref_primary_10_1039_c3md00098b crossref_primary_10_1016_j_nucmedbio_2011_01_002 crossref_primary_10_1002_syn_20891 crossref_primary_10_1002_cmdc_200700067 crossref_primary_10_3389_fcvm_2021_732282 crossref_primary_10_1080_13880200490505654 crossref_primary_10_1016_j_neuropharm_2012_08_011 crossref_primary_10_1021_jm070860r crossref_primary_10_1016_j_bmc_2013_03_074 crossref_primary_10_1016_j_bmcl_2012_07_003 crossref_primary_10_1176_appi_psy_49_4_347 crossref_primary_10_1007_s00044_024_03291_3 crossref_primary_10_1016_j_bmcl_2005_01_037 crossref_primary_10_1016_j_bmc_2003_10_011 crossref_primary_10_1016_j_bmc_2005_09_008 crossref_primary_10_1016_j_pharmthera_2006_04_007 crossref_primary_10_1107_S160053681005155X crossref_primary_10_1021_cr300113a crossref_primary_10_1176_appi_psy_49_3_258 crossref_primary_10_1002_syn_20748 crossref_primary_10_1002_ardp_200400997 crossref_primary_10_1007_s11011_015_9753_2 crossref_primary_10_1124_jpet_112_202911 crossref_primary_10_1002_jlcr_3558 crossref_primary_10_1021_jm101323b crossref_primary_10_1016_j_bmcl_2010_07_096 crossref_primary_10_1016_j_bmc_2009_04_031 crossref_primary_10_1186_s40658_018_0219_6 crossref_primary_10_3389_fnins_2016_00451 crossref_primary_10_1002_cbic_200300784 crossref_primary_10_1080_14756360701830023 crossref_primary_10_1016_S1359_6446_05_03491_4 crossref_primary_10_1211_jpp_58_2_0008 crossref_primary_10_1021_cr050263h crossref_primary_10_1016_j_neuropharm_2010_09_011 crossref_primary_10_1016_j_bmc_2008_11_044 |
ContentType | Journal Article |
Copyright | Copyright © 2003 Bentham Science Publishers |
Copyright_xml | – notice: Copyright © 2003 Bentham Science Publishers |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QO 7T7 7TK 7U7 7U9 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK ABUWG AFKRA BENPR C1K CCPQU FR3 FYUFA GHDGH H94 K9. M0S M1P M7N P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.2174/1381612033391199 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts Toxicology Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Technology Research Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-4286 |
EndPage | 671 |
ExternalDocumentID | 1007537301 12570797 10_2174_1381612033391199 http_www_eurekaselect_com_openurl_content_php_genre_article_issn_13816128_volume_9_issue_8_spage_643 |
Genre | Journal Article Review |
GroupedDBID | --- .5. 0R~ 29F 36B 3V. 4.4 53G 5GY 69Q 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AAEGP ABEEF ABJNI ABUWG ABVDF ACGFO ACGFS ACITR ACIWK ACPRK ADBBV AENEX AFKRA AFRAH AFUQM AGJNZ AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS ANTIV BENPR BPHCQ BVXVI C1A CCPQU CS3 DU5 EBS EJD F5P FYUFA GH2 HMCUK HZ~ IPNFZ KCGFV KFI M1P O9- P2P PQQKQ PROAC PSQYO Q2X RIG UKHRP AAYXX AFHZU CITATION PHGZM PHGZT PJZUB PPXIY PUEGO ACZAY CGR CUY CVF ECM EIF NPM 7QL 7QO 7T7 7TK 7U7 7U9 7XB 8FD 8FK C1K FR3 H94 K9. M7N P64 PKEHL PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-b445t-80218140dcbd66883f906f59115dd9a1a8ba4408c10a938c1a9b4ee492faf43a3 |
IEDL.DBID | 7X7 |
ISSN | 1381-6128 |
IngestDate | Fri Sep 05 13:36:05 EDT 2025 Sat Aug 23 13:35:41 EDT 2025 Thu Jan 02 23:03:59 EST 2025 Wed Oct 01 02:49:36 EDT 2025 Thu Apr 24 23:05:32 EDT 2025 Tue Aug 27 15:42:25 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b445t-80218140dcbd66883f906f59115dd9a1a8ba4408c10a938c1a9b4ee492faf43a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
PMID | 12570797 |
PQID | 215123041 |
PQPubID | 42716 |
PageCount | 29 |
ParticipantIDs | proquest_miscellaneous_73011781 proquest_journals_215123041 pubmed_primary_12570797 crossref_primary_10_2174_1381612033391199 crossref_citationtrail_10_2174_1381612033391199 benthamscience_primary_http_www_eurekaselect_com_openurl_content_php_genre_article_issn_13816128_volume_9_issue_8_spage_643 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2003-01-01 |
PublicationDateYYYYMMDD | 2003-01-01 |
PublicationDate_xml | – month: 01 year: 2003 text: 2003-01-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United Arab Emirates |
PublicationPlace_xml | – name: United Arab Emirates – name: Schiphol |
PublicationTitle | Current pharmaceutical design |
PublicationTitleAlternate | CPD |
PublicationYear | 2003 |
Publisher | Bentham Science Publishers Ltd |
Publisher_xml | – name: Bentham Science Publishers Ltd |
SSID | ssj0012914 |
Score | 2.025405 |
SecondaryResourceType | review_article |
Snippet | The dopamine D3 receptor has been the subject of a tremendous amount of research since its discovery in 1990. A previous review of this subject [3] described... |
SourceID | proquest pubmed crossref benthamscience |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 643 |
SubjectTerms | Amino Acid Sequence Animals Benzamides - chemistry Benzamides - pharmacology Benzamides - therapeutic use Binding Sites Drug Design Humans Ligands Molecular Sequence Data Parkinson Disease - drug therapy Parkinson Disease - metabolism Receptors, Dopamine D2 - drug effects Receptors, Dopamine D2 - metabolism Receptors, Dopamine D2 - physiology Receptors, Dopamine D3 Schizophrenia - drug therapy Schizophrenia - metabolism Second Messenger Systems - physiology Substance-Related Disorders - drug therapy Substance-Related Disorders - metabolism Tetrahydronaphthalenes - chemistry Tetrahydronaphthalenes - pharmacology Tetrahydronaphthalenes - therapeutic use |
Title | Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders |
URI | http://www.eurekaselect.com/openurl/content.php?genre=article&issn=13816128&volume=9&issue=8&spage=643 https://www.ncbi.nlm.nih.gov/pubmed/12570797 https://www.proquest.com/docview/215123041 https://www.proquest.com/docview/73011781 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection (ProQuest) customDbUrl: eissn: 1873-4286 dateEnd: 20081231 omitProxy: true ssIdentifier: ssj0012914 issn: 1381-6128 databaseCode: 7X7 dateStart: 20000101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1873-4286 dateEnd: 20081231 omitProxy: true ssIdentifier: ssj0012914 issn: 1381-6128 databaseCode: BENPR dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagvXAA8WYpFB9QJaRGm6zzsE-osK0qBFWEWmlvIzt22gqaTZvtoeLIH2fGcbIUqZwiOc5D8cw338TzYOx9bnOrnTORNCKOUuGqSNWzOhJVFTubOC0yykb-dpQfnqRfFtkixOZ0IaxywEQP1HZZ0T_yqTdN6HsnH9vLiJpG0eZq6KBxn20myFRIqIvF6G-hJUv6nrYyQQ9pJvtdSuLgUxrDoVgIgdpOhV8fGgT5M30RDM9tM3UH9_Q26OAxexTII9_rV_sJu-eap2yn7KtP3-zy43UyVbfLd3i5rkt984z9LikWC5GNnzd8PiZL8bngc3SdL5BvcmSRrkU3nH89P6UkYK47Xi5XFFKED_7r_nyPcrI6jpyX-wIfAUM5XtUPjHHUOHmo8dk9ZycH-8efD6PQgyEyaZqt0IARB0hjWxmb51KKWsV5neFHy6xVOtHSaGpaXSWxVgIPWpnUuVTNal2nQosXbKNZNu4V46j9uaozPIekx8oKpcfqwuTWxFWRqdmE_bq9BtD2BTd86hGgZAC-vfuhO98hCFA6ILQYA4rrp67E7VkLXvEgKB4QlEJYbgk95IMCL9UgwcM2IC2bsOmw4FCF8ujUpeMnoJtEMgP_ysyEfRivGN707rlbgwxBAIkORpGesHfjWdRu2rLRjVted-Dxt5A442UveOsnUfvBQhWv_3vnLfbARx_6f0Zv2Mbq6tq9RRa1MtteV7bZ5qf9o_L7HxkEI0o |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKOcABxJulQH2ASkiNNonzcA4IVSzVlm6rPWylvQ127NAKmg1kK7TiyO_hPzLjPJYilVtPkRzHtjTveGY-xl4lJjHKWu1JLXwvEjb3siIsPJHnvjWBVSKmauSj42R8En2cx_MN9rurhaG0yk4nOkVtFjn9Ix8604Sxd_Cu-uYRaBRdrnYIGg1XHNrVD4zY6rcHIyTv6zDc_zB7P_ZaUAFPR1G8RI1MRi3yTa5NkkgpisxPihhlPjYmU4GSWhEKcx74KhP4UJmOrI2ysFBFJJTAdW-wmxEehVr1p_M-vkPLGTQYujLAiCyUza0o-fxDGsMhXwiBO1Gj2TsajcqpOm8N3WWzeIWv62ze_j12t3VW-V7DXffZhi0fsJ1p0-16tctn6-Ktepfv8Om6D_bqIfs1pdwv1KT8rOSjvjiLjwQfYah-jv4tR6_VVhj288nZZyo65qrm08WSUphw47_W53tUA1Zz9LG5ayjS6myOXzUDfd42Tu56itaP2Mm1kOcx2ywXpX3KOGqbJCtifIdOlpE5cqtRqU6M9vM0zsIB-3mZBlA1DT5cqRMgJwKe3n5RtUMkAuRGaCHNgOoICAW5Oq3ACTq0gg6kuqElt4TGxEAGTopAgjMTgG7ggA07gkPetmMnVJCvgGEZ8Qz8yzMD9qb_ojvp1XO3Oh6CVinV0IvQgG33b1Gb0BWRKu3iogan71OJM540jLfeieAO0yx99t-Vt9mt8exoApOD48MtdttlPrr_Vc_Z5vL7hX2BHtxSv3Ryw9mn6xbUP-HqXeQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Progress+in+Developing+D3+Dopamine+Receptor+Ligands+as+Potential+Therapeutic+Agents+for+Neurological+and+Neuropsychiatric+Disorders&rft.jtitle=Current+pharmaceutical+design&rft.au=Luedtke%2C+R+R&rft.au=Mach%2C+R+H&rft.date=2003-01-01&rft.pub=Bentham+Science+Publishers+Ltd&rft.issn=1381-6128&rft.eissn=1873-4286&rft.volume=9&rft.issue=8&rft.spage=643&rft_id=info:doi/10.2174%2F1381612033391199&rft.externalDocID=1007537301 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1381-6128&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1381-6128&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1381-6128&client=summon |